• OPEN AN ACCOUNT
Indian Indices
Sensex
82,814.71 316.57
( 0.38%)
Global Indices
Nasdaq
49,410.74 -272.93
(-0.55%)
Dow Jones
6,881.90 -20.41
(-0.30%)
Hang Seng
56,838.27 -629.56
(-1.10%)
Nikkei 225
10,620.33 -65.85
(-0.62%)
Forex
USD-INR
90.70 0.01
(0.01%)
EUR-INR
107.23 -0.14
(-0.13%)
GBP-INR
122.83 -0.27
(-0.22%)
JPY-INR
0.59 0.00
(-0.51%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5552288
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
23.43
107358.09
EPS(TTM)
Face Value()
Div & Yield %
56.72
2
1.2
 

hindustan unilever ltd
HBL Engg gains on securing Rs 800-cr KAVACH contract from BLW
Feb 11,2026
The contract, awarded by a domestic entity, is to be executed within a period of 12 months. The company said that none of the promoters has any interest in the awarding entity, and the transaction does not fall under related-party transactions.

HBL Engineering (formerly known as HBL Power Systems) manufactures different types of batteries, including lead acid, NiCad, silver zinc, lithium, and railway & defense electronics and other products.

The company reported a more than fourfold jump in consolidated net profit to Rs 387.27 crore in Q2 FY26, compared with Rs 87.26 crore in the same quarter last year. Revenue from operations surged 134.7% YoY to Rs 1,222.90 crore in Q2 September 2025.